Sensus Healthcare, Inc. (NASDAQ:SRTS) Sees Large Growth in Short Interest

Sensus Healthcare, Inc. (NASDAQ:SRTS) saw a significant increase in short interest during the month of December. As of December 15th, there was short interest totalling 583,500 shares, an increase of 20.0% from the November 30th total of 486,100 shares. Currently, 4.4% of the shares of the stock are sold short. Based on an average trading volume of 174,600 shares, the days-to-cover ratio is presently 3.3 days.

Institutional Investors Weigh In On Sensus Healthcare

Several large investors have recently modified their holdings of SRTS. Truvestments Capital LLC acquired a new position in shares of Sensus Healthcare in the 3rd quarter valued at about $32,000. Geode Capital Management LLC grew its holdings in shares of Sensus Healthcare by 8.5% during the 3rd quarter. Geode Capital Management LLC now owns 146,404 shares of the company’s stock valued at $849,000 after acquiring an additional 11,525 shares in the last quarter. Sachetta LLC increased its stake in shares of Sensus Healthcare by 12.9% during the 2nd quarter. Sachetta LLC now owns 118,354 shares of the company’s stock worth $631,000 after purchasing an additional 13,544 shares during the last quarter. XTX Topco Ltd increased its position in Sensus Healthcare by 76.0% during the third quarter. XTX Topco Ltd now owns 31,530 shares of the company’s stock worth $183,000 after buying an additional 13,619 shares during the last quarter. Finally, Cubist Systematic Strategies LLC acquired a new stake in shares of Sensus Healthcare in the second quarter worth about $156,000. 25.30% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on the stock. Maxim Group increased their target price on shares of Sensus Healthcare from $12.00 to $14.00 and gave the stock a “buy” rating in a research report on Friday, November 15th. HC Wainwright increased their target price on Sensus Healthcare from $10.00 to $11.00 and gave the company a “buy” rating in a research note on Monday, November 18th.

Sensus Healthcare Price Performance

Shares of SRTS traded down $0.30 during trading hours on Tuesday, reaching $6.87. 195,104 shares of the company’s stock traded hands, compared to its average volume of 273,232. The business’s fifty day simple moving average is $7.62 and its two-hundred day simple moving average is $6.58. The firm has a market capitalization of $112.59 million, a price-to-earnings ratio of 12.05 and a beta of 1.16. Sensus Healthcare has a twelve month low of $2.36 and a twelve month high of $9.33.

Sensus Healthcare Company Profile

Sensus Healthcare, Inc, a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters.